Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Globus Maritime (GLBS) Prices 10M Share Offering at $5/sh
-
Globus Maritime Limited Announces Pricing of $50 Million Registered Direct Offering
-
UPDATE: Euroseas Ltd. (ESEA) PT Raised to $38 at Maxim Group (correction)
-
Mericsson Acquisition Corporation (MLXAU) Announces 4M Unit IPO at $10/unit
-
SELLAS Life Sciences Group (SLS) PT Raised to $21 at Maxim Group, Following Clinical Business Update
-
Maxim Group Maintains Bullish View on Stamps.com (STMP) Following CFO Meeting
-
InvestorNewsBreaks – Cognos Therapeutics Corp. Signs Agreement to Work with Maxim Group LLC for Investment Banking, Financial Advisory Services
-
UPDATE: Maxim Group Starts Research Solutions Inc. (RSSS) at Buy, $6 PT
-
ReShape Lifesciences Completes Merger with Obalon Therapeutics
-
Aethlon Medical (AEMD) PT Nearly Doubled to $11 at Maxim Group
-
Healthier Choices Management Corp. Announces Expiration of Rights Offering
-
Healthier Choices Management Corp. Announces Expiration of Rights Offering
-
Recon Technology (RCON) Sells 8.8M Shares and Warrants in Registered Direct Offering
-
Recon Technology Announces Pricing of $55.0 million Registered Direct Offering
-
MediciNova to Participate in Maxim Group LLC Fireside Chat
-
MediciNova to Participate in Maxim Group LLC Fireside Chat
-
Atlanticus Holdings Corporation Closes Preferred Stock Offering
-
Atlanticus Holdings Corporation Closes Preferred Stock Offering
-
IPO for SPAC Blue Safari Group Acquisition (BSGA) Opens at $9.97
-
Aethlon Medical (AEMD) Announced a Direct 1.4M Share Offering at $9/sh
-
Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Blue Safari Group Acquisition Corp. (BSGA) Prices 5M Unit IPO at $10/Unit
-
Celsius Holdings Inc. (CELH) Prices 6.518M Share Common Offering at $62.50/Sh
-
Celsius Announces Pricing of Public Offering of Common Stock
-
Blue Safari Group Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
-
Atlanticus Holdings Corporation Prices $70 Million Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Prices $70 Million Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Hldgs (ATLC) to Offer Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Offering of Series B Cumulative Perpetual Preferred Stock
-
Ucommune International Ltd. Announces Unaudited First Quarter 2021 Financial Results
-
Orbsat Corp Announces Closing of Upsized $14.4 Million Public Offering
-
OceanTech Acquisitions I Corp. Announces Closing of $100.0 Million Initial Public Offering
-
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
-
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
-
Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
-
Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
-
Esports Entertainment Group (GMBL) Announces Private Placement of $35 Million Convertible Notes with $17.50 Conversion Price
-
Esports Entertainment Group Announces Private Placement of $35 Million Convertible Notes with $17.50 Conversion Price
-
Orbsat Corp. (OSAT) Prices 2.88M Unit Offering at $5/Unit; Announces Nasdaq Uplisting
-
Orbsat Corp Announces Pricing of Upsized $14.4 Million Underwritten Public Offering and Uplisting to Nasdaq
-
Zivo Bioscience Inc. (ZIVO) Prices 2.76M Unit Upsized Offering at $5/Unit; Announces Up-Listing to Nasdaq
-
OceanTech Acquisitions I Corp. (OTEC) Prices 10M Unit IPO at $10/Unit
-
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
-
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
-
OceanTech Acquisitions I Corp. Announces Pricing of $100.0 Million Initial Public Offering
-
Sphere 3D Corp. Announces Closing of $7.9 Million Public Offering and Partial Exercise of Overallotment Option
-
Annovis Bio, Inc. Announces Closing of $50 Million Public Offering
-
Reviva Pharmaceuticals (RVPH) Prices 8M Share Upsized $30M Share Common Offering
-
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering

